Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 May, 2017 14:26 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
VA Tech Wabag bags order worth USD 105.5 mn - 23-May-2017 13:23
NIIT Technologies enters into partnership with Arago - 23-May-2017 13:19
Zydus Cadilla gets final nod for Cyproheptadine HCl tablets - 23-May-2017 13:09
BHEL commissions 1,980 MW supercritical thermal power project - 23-May-2017 13:07
GAIL quarterly profit plummets 68.73% - 23-May-2017 11:33
Tata Power's renewable capacity crosses 2,000 MW - 23-May-2017 11:26
Prakash Industries gets nod for issuing new FCCBs - 23-May-2017 08:12
Karnataka Bank enters into MoU with LIC - 23-May-2017 08:08
Tata Power's generation crosses 52,000 MUs in FY17 - 23-May-2017 08:00
Supreme Infra India bags two EPC projects worth Rs 2.44 bn - 23-May-2017 07:57
HCC's JV secures Rs 6.73 bn order from Rajasthan Govt - 22-May-2017 16:03
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer